跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe
Approved
STANDARD
LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe
Sun Pharma ANZ Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Oct 28, 2025
Approval ID
e2b97bea5ba04d60
Company
Sun Pharma ANZ Pty Ltd
Type
Standard
Approval Details
Approval Id
e2b97bea5ba04d60
Product Name
LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe
Artg Id
516828
Artg Name
LACREO lanreotide (as acetate) 60 mg/0.2 mL solution for injection prefilled syringe
Sponsor
Sun Pharma ANZ Pty Ltd
Company Detail Path
/organization/sun-pharma-anz-pty-ltd
Artg Date
2025-10-24
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Oct 28, 2025
Approval ID
e2b97bea5ba04d60
Type
Standard
Back to TGA Approvals